| Net Cash Provided by (Used in) Operating Activities |
$532,195 |
USD |
-124% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$650,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$120,936 |
USD |
36% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$244,010 |
USD |
-87% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$745,861 |
USD |
64% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$293 |
USD |
99% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$290,336 |
USD |
5.7% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$841,395 |
USD |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |